Big Move For Outlook Therapeutics, Inc.

Thu, Oct 19, 2023 at 07:18 PM
Big Move For Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. (OTLK:NASDAQ) shot up at $0.66, a gain of 39.9%. On Thu, Oct 19, 2023, OTLK:NASDAQ hit a New 2-Week High of $0.66. The stock appeared on our News Catalysts scanner on Wed, Oct 18, 2023 at 07:24 AM in the 'INVESTOR UPDATE' category. From Thu, Oct 05, 2023, the stock recorded 90.00% Up Days and 72.73% Green Days

The stock spiked on Thu, Oct 19, 2023 at $0.9 with a volume of 125M+.

About Outlook Therapeutics, Inc. (OTLK:NASDAQ)

Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.